Kitidee, K., Amonyingcharoen, S., Preedagasamzin, S., Atjanasuppat, K., Sawaisorn, P., Srimorkun, P., Petvises, S., Chaicumpa, W., Borwornpinyo, S., Anurathapan, U., Hongeng, S. (2025). Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells facilitates neuroblastoma cell targeting and killing in vitro. PLoS ONE. https://doi.org/10.1371/journal.pone.0325389